Evaluation of the National Accreditation Program for Rectal Cancer and Association with Oncologic Outcomes After Proctectomy.

Adan Z Becerra¹, Ingrid M Lizarraga^2,3, Ronald J Weigel^2,3, Samantha Hendren⁴, Steven D Wexner⁵, Totadri Dhimal⁶, Bailey K Hilty Chu⁶, Christopher T Aquina^7,8, Fergal J Fleming⁶

¹Arine Inc., San Francisco, CA.

²Department of Surgery, University of Iowa Carver College of Medicine, Iowa City, IA.

³American College of Surgeons Cancer Research Program, Chicago, IL.

⁴Department of Surgery at Indiana University, Indianapolis, IN.

⁵Department of Colon and Rectal Surgery, Surgical Oncology, MedStar Health, Washington, DC.

⁶Surgical Health Outcomes Research Enterprise (SHORE), Department of Surgery, University of Rochester Medical Center, Rochester, NY.

⁷Department of Colon & Rectum Surgery, AdventHealth, Orlando, FL.

⁸Surgical Health Outcomes Consortium (SHOC), Advent Health Digestive Institute, Orlando, FL.

PubMed DOI

Abstract

BACKGROUND: Circumferential resection margin (CRM) positivity is a validated predictor of local recurrence and survival in rectal cancer and reflects multidisciplinary care quality. The National Accreditation Program for Rectal Cancer (NAPRC), launched in 2017, standardizes rectal cancer care, but national oncologic outcome data remain limited. STUDY DESIGN: We performed a retrospective National…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.